SERIES:ADVANCES IN IMMUNOLOGY THAT CLINICIANS SHOULD KNOW(III)
The significance of toll-like receptors in human diseases
Read
15839
Timeswas read the article
2023
Total PDF
13816
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 153 | 62 | 215 |
| 2025 11 | 387 | 114 | 501 |
| 2025 10 | 248 | 59 | 307 |
| 2025 9 | 238 | 36 | 274 |
| 2025 8 | 256 | 41 | 297 |
| 2025 7 | 243 | 26 | 269 |
| 2025 6 | 275 | 26 | 301 |
| 2025 5 | 342 | 29 | 371 |
| 2025 4 | 290 | 7 | 297 |
| 2025 3 | 292 | 14 | 306 |
| 2025 2 | 248 | 17 | 265 |
| 2025 1 | 255 | 34 | 289 |
| 2024 12 | 304 | 31 | 335 |
| 2024 11 | 182 | 31 | 213 |
| 2024 10 | 127 | 18 | 145 |
| 2024 9 | 198 | 24 | 222 |
| 2024 8 | 118 | 16 | 134 |
| 2024 7 | 196 | 27 | 223 |
| 2024 6 | 162 | 13 | 175 |
| 2024 5 | 208 | 55 | 263 |
| 2024 4 | 224 | 41 | 265 |
| 2024 3 | 347 | 18 | 365 |
| 2024 2 | 297 | 20 | 317 |
| 2024 1 | 246 | 21 | 267 |
| 2023 12 | 198 | 35 | 233 |
| 2023 11 | 237 | 38 | 275 |
| 2023 10 | 233 | 41 | 274 |
| 2023 9 | 123 | 12 | 135 |
| 2023 8 | 84 | 13 | 97 |
| 2023 7 | 141 | 13 | 154 |
| 2023 6 | 173 | 16 | 189 |
| 2023 5 | 199 | 22 | 221 |
| 2023 4 | 168 | 8 | 176 |
| 2023 3 | 129 | 10 | 139 |
| 2023 2 | 100 | 17 | 117 |
| 2023 1 | 68 | 6 | 74 |
| 2022 12 | 46 | 18 | 64 |
| 2022 11 | 60 | 9 | 69 |
| 2022 10 | 33 | 18 | 51 |
| 2022 9 | 56 | 18 | 74 |
| 2022 8 | 28 | 29 | 57 |
| 2022 7 | 29 | 19 | 48 |
| 2022 6 | 32 | 15 | 47 |
| 2022 5 | 29 | 18 | 47 |
| 2022 4 | 75 | 30 | 105 |
| 2022 3 | 24 | 15 | 39 |
| 2022 2 | 22 | 10 | 32 |
| 2022 1 | 48 | 19 | 67 |
| 2021 12 | 15 | 15 | 30 |
| 2021 11 | 20 | 8 | 28 |
| 2021 10 | 42 | 19 | 61 |
| 2021 9 | 27 | 12 | 39 |
| 2021 8 | 32 | 9 | 41 |
| 2021 7 | 15 | 12 | 27 |
| 2021 6 | 10 | 8 | 18 |
| 2021 5 | 15 | 9 | 24 |
| 2021 4 | 17 | 11 | 28 |
| 2021 3 | 20 | 6 | 26 |
| 2021 2 | 30 | 15 | 45 |
| 2021 1 | 42 | 14 | 56 |
| 2020 12 | 1 | 0 | 1 |
| 2020 11 | 0 | 1 | 1 |
| 2020 10 | 0 | 2 | 2 |
| 2020 7 | 0 | 1 | 1 |
| 2020 6 | 0 | 1 | 1 |
| 2020 5 | 0 | 2 | 2 |
| 2020 4 | 0 | 3 | 3 |
| 2020 2 | 0 | 1 | 1 |
| 2020 1 | 0 | 2 | 2 |
| 2019 10 | 0 | 3 | 3 |
| 2019 9 | 0 | 1 | 1 |
| 2019 7 | 0 | 1 | 1 |
| 2019 6 | 0 | 1 | 1 |
| 2019 5 | 0 | 19 | 19 |
| 2018 2 | 62 | 8 | 70 |
| 2018 1 | 10 | 0 | 10 |
| 2017 12 | 0 | 1 | 1 |
| 2017 11 | 6 | 17 | 23 |
| 2017 10 | 17 | 3 | 20 |
| 2017 9 | 16 | 13 | 29 |
| 2017 8 | 9 | 7 | 16 |
| 2017 7 | 6 | 6 | 12 |
| 2017 6 | 5 | 22 | 27 |
| 2017 5 | 18 | 9 | 27 |
| 2017 4 | 12 | 8 | 20 |
| 2017 3 | 15 | 36 | 51 |
| 2017 2 | 27 | 20 | 47 |
| 2017 1 | 19 | 2 | 21 |
| 2016 12 | 18 | 7 | 25 |
| 2016 11 | 15 | 7 | 22 |
| 2016 10 | 23 | 12 | 35 |
| 2016 9 | 21 | 9 | 30 |
| 2016 8 | 22 | 19 | 41 |
| 2016 7 | 13 | 1 | 14 |
| 2016 6 | 25 | 10 | 35 |
| 2016 5 | 17 | 13 | 30 |
| 2016 4 | 18 | 27 | 45 |
| 2016 3 | 17 | 9 | 26 |
| 2016 2 | 16 | 18 | 34 |
| 2016 1 | 30 | 28 | 58 |
| 2015 12 | 13 | 10 | 23 |
| 2015 11 | 17 | 7 | 24 |
| 2015 10 | 23 | 6 | 29 |
| 2015 9 | 15 | 3 | 18 |
| 2015 8 | 10 | 6 | 16 |
| 2015 7 | 13 | 7 | 20 |
| 2015 6 | 11 | 3 | 14 |
| 2015 5 | 32 | 11 | 43 |
| 2015 4 | 11 | 9 | 20 |
| 2015 3 | 28 | 11 | 39 |
| 2015 2 | 15 | 3 | 18 |
| 2015 1 | 24 | 4 | 28 |
| 2014 12 | 22 | 10 | 32 |
| 2014 11 | 23 | 9 | 32 |
| 2014 10 | 24 | 9 | 33 |
| 2014 9 | 30 | 6 | 36 |
| 2014 8 | 11 | 1 | 12 |
| 2014 7 | 11 | 6 | 17 |
| 2014 6 | 14 | 6 | 20 |
| 2014 5 | 11 | 4 | 15 |
| 2014 4 | 20 | 4 | 24 |
| 2014 3 | 106 | 16 | 122 |
| 2014 2 | 138 | 15 | 153 |
| 2014 1 | 91 | 9 | 100 |
| 2013 12 | 94 | 7 | 101 |
| 2013 11 | 78 | 12 | 90 |
| 2013 10 | 79 | 14 | 93 |
| 2013 9 | 98 | 20 | 118 |
| 2013 8 | 133 | 20 | 153 |
| 2013 7 | 84 | 12 | 96 |
| 2013 6 | 44 | 7 | 51 |
| 2013 5 | 50 | 5 | 55 |
| 2013 4 | 31 | 12 | 43 |
| 2013 3 | 20 | 7 | 27 |
| 2013 2 | 37 | 5 | 42 |
| 2013 1 | 27 | 3 | 30 |
| 2012 12 | 10 | 4 | 14 |
| 2012 11 | 6 | 2 | 8 |
| 2012 10 | 2 | 1 | 3 |
| 2009 8 | 3396 | 0 | 3396 |
Show all
